Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Ambassador Smita Pant discusses pharma ties in Uzbekistan
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 65004, member: 636"] India’s Ambassador to Uzbekistan, Smita Pant, met with Indian pharmaceutical companies in Uzbekistan on Wednesday to discuss topics such as joint ventures, investment opportunities, registration processes, and cooperation in traditional medicine. The Indian Embassy in Uzbekistan noted that Ambassador Pant highlighted the positive impact of the Indian pharmaceutical sector in the country. Earlier, on Oct. 6, Pant met Abdulla Azizov, chairman of Uzbekistan’s Pharmaceutical Industry Agency, to further explore areas of mutual interest in pharmaceuticals and traditional medicine. India and Uzbekistan have continued to strengthen their partnership, recently holding the ninth Joint Working Group meeting on Counter Terrorism in Tashkent to discuss collaboration in information sharing and best practices. India was among the first nations to recognize Uzbekistan’s independence, establishing diplomatic relations in 1992 and declaring a Strategic Partnership in 2011. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Ambassador Smita Pant discusses pharma ties in Uzbekistan
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top